ArticleFrontiers in pharmacology2024

Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis.

Junli Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.